Lola
Date of Foundation
2024

Lola

longevity store for all testing and treatments

The Idea origin story

Rather than describing my startup as simply a "longevity store," I'd clarify it by saying: "Lola is a comprehensive platform dedicated to longevity. Our platform not only provides thorough testing to determine an individual's unique health status but also coordinates and administers treatments designed to promote and support a longer and healthier life. We've truly revolutionized the way people approach their health and longevity."

The Mission

"Empowering individuals to live longer, healthier lives by providing tailored testing and personalized longevity treatments."

Clients

Our customers are health-conscious individuals seeking advanced, personalized care to enhance their longevity.

Problems we solve

Client’s problem

1. screen for issues and find problems 2x faster than waiting for symptoms 2. give peace of mind 3. help people towards healthcare that is personalised

Confirmation of problem

Disease is prevalent, people continue to die from the horseman diseases, we don't know what is happening on the inside, health span is important

Solution

We provide a one-stop-shop for longevity-oriented health screening and treatments, aiming to detect potential issues early, offer peace of mind with accurate results, and deliver personalized healthcare tailored to each individual's needs.

Our technologies

This solution is based on technologies

shopify and software built in-house

How it works

Our platform performs detailed health screening and offers customized longevity treatments. Our unique diagnostic-treatment combination sets us apart.

Value for the client

We generate revenue through health tests and treatments, also exploring partnerships and subscription models for sustained monitoring.

Market and strategy

Market size

120

mln/year

We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal

10

% of the market

Is our goal in the next 3 years

Team

My name’s

Ricky Thomas

My key role in the product

"My key role is PitchBob's recommendation and I'm responsible for service upgrades, growth extension, feedback analysis, & securing partnerships."

Team size and key members

Our team comprises Ricky, a successful CEO; Alex, an experienced software engineer; Kostas, specializing in early cancer detection and Shriya, founder of Verve Clinics.

Competitors

Competitors

Our main competitors are individual testing services and boutique outlets. However, none offer comprehensive longevity solutions like we do in one place.

Our Advantages

Our product flaunts top-tier quality designed for enduring usage. With exceptional customer service, we take pride in our stellar ratings and reviews that testify to our unwavering commitment to client satisfaction.

Business model

single purchase and subscriptions. AOV £210

Traction

Our sales average £60k monthly with consistent growth in subscriptions. We offer cost-effective blood tests covering 70+ markers, supported by a nationwide phlebotomy network. Also, we've successfully launched our first supplement and established multiple partnerships.

reach £5m in revenue run rate

Metrics

Our key product metrics such as sales, margins, and subscriptions are all on an upward trajectory. This consistent growth trend validates our business model's effectiveness and market acceptance of our solutions.

Incorporation

Our company incorporated in

delaware

Key risks

The main risks of our startup could be regulatory challenges due to healthcare industry standards, potential customer apprehension towards personalized treatments and testing methods, or the rapid advancement in healthcare technology outdating our current offerings.

Investments

$

200000

We raised investments

Our Investors

angels around 40%

Rising Investments

$

500000

Currently, we are raising investments

$

5000000

Estimated pre-investment valuation of the company

We’re looking for a co-founders

Open positions

Article

Read

Additional information

Our mobile apps seamlessly track metrics and sync with wearables for ongoing monitoring. Currently targeting the UK, we're set to expand into the US market upon securing funding.

Growth